Allurion Technologies Inc. logo

Allurion Technologies Inc.

ALUR | NYSE
Chart Builder DCF Calculator
$0.80
+$0.07 (+9.57%)
Mar 19, 2026, 3:08 PM ET · Market open

Company Profile

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Key Executives

Name Position
Shantanu K. Gaur Co-Founder, Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Brendan Michael Gibbons Chief Legal Officer & Corporate Secretary
Ojas A. Buch Chief Operating Officer
Alexandra van der Stap Vice President of Global Marketing
Laurent Laffineur Vice President of International Sales & Marketing
Matt Wright Vice President of People
Ram Chuttani MD, Chief Medical Officer & Founding Partner
Samuel G. Levy Co-Founder

Latest SEC Filings

Date Type Title
Feb 25, 2026 8-K Current Report
Feb 23, 2026 8-K Current Report
Feb 17, 2026 5 Filing
Feb 17, 2026 5 Filing
Jan 16, 2026 EFFECT Filing
Jan 20, 2026 424B3 Filing
Jan 12, 2026 8-K Current Report
Jan 09, 2026 S-3 Filing
Dec 30, 2025 EFFECT Filing
Dec 29, 2025 POS AM Filing
View All SEC Filings
Allurion Technologies Inc.
Allurion Technologies Inc. logo
Country United States
IPO Date Mar 28, 2021
Industry Medical - Devices
Sector Healthcare
Employees 134
CEO Shantanu K. Gaur

Contact Details

11 Huron Drive Natick, Massachusetts 01760 United States

Stock Details

Ticker Symbol ALUR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001964979
CUSIP Number 02008G102
ISIN Number US02008G2012
SIC Code 3841

© 2026 bestshares.com. All rights reserved.